Axcelis (ACLS) Stock Forecast, Price Target & Predictions
ACLS Stock Forecast
Axcelis stock forecast is as follows: an average price target of $137.00 (represents a 41.27% upside from ACLS’s last price of $96.98) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
ACLS Price Target
The average price target for Axcelis (ACLS) is $137.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $174.00 to $100.00. This represents a potential 41.27% upside from ACLS's last price of $96.98.
ACLS Analyst Ratings
According to 7 Wall Street analysts, Axcelis's rating consensus is 'Buy'. The analyst rating breakdown for ACLS stock is 0 'Strong Buy' (0.00%), 6 'Buy' (85.71%), 1 'Hold' (14.29%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Axcelis Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 12, 2024 | Christian Schwab | Craig-Hallum | $174.00 | $144.57 | 20.36% | 79.42% |
| May 03, 2024 | Christian Schwab | Craig-Hallum | $130.00 | $106.64 | 21.91% | 34.05% |
| Jan 05, 2023 | Quinn Bolton | Needham | $100.00 | $81.75 | 22.32% | 3.11% |
The latest Axcelis stock forecast, released on Jul 12, 2024 by Christian Schwab from Craig-Hallum, set a price target of $174.00, which represents a 20.36% increase from the stock price at the time of the forecast ($144.57), and a 79.42% increase from ACLS last price ($96.98).
Axcelis Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $174.00 | $152.00 |
| Last Closing Price | $96.98 | $96.98 | $96.98 |
| Upside/Downside | -100.00% | 79.42% | 56.73% |
In the current month, the average price target of Axcelis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Axcelis's last price of $96.98. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 02, 2024 | B. Riley | Buy | Buy | Hold |
| Jul 15, 2024 | Benchmark | Buy | Buy | Hold |
| Jul 12, 2024 | B. Riley | Buy | Buy | Hold |
| Jul 12, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Jun 20, 2024 | B. Riley Securities | Underperform | Underperform | Hold |
| Jun 20, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Jun 20, 2024 | B. Riley | Buy | Buy | Hold |
| May 03, 2024 | B. Riley Securities | Underperform | Underperform | Hold |
| May 03, 2024 | Craig-Hallum | Buy | Buy | Hold |
| May 03, 2024 | Craig-Hallum | - | Buy | Upgrade |
Axcelis's last stock rating was published by B. Riley on Aug 02, 2024. The company gave ACLS a "Buy" rating, the same as its previous rate.
Axcelis Financial Forecast
Axcelis Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $310.29M | $292.33M | $273.97M | $254.02M | $266.05M | $229.18M | - | $203.59M | $205.68M | $176.69M | $147.27M | $132.78M | $122.20M | $110.41M | $122.97M | $118.99M | $107.72M | $69.45M |
| Avg Forecast | $380.00M | $375.00M | $375.00M | $370.00M | $312.34M | $300.20M | $283.94M | $267.26M | $262.16M | $255.00M | $250.06M | $242.61M | $297.92M | $280.24M | $256.55M | $239.80M | $248.64M | $224.39M | $211.47M | $193.11M | $190.05M | $170.08M | $137.27M | $126.43M | $118.40M | $109.96M | $116.18M | $116.25M | $96.44M | $70.90M |
| High Forecast | $380.36M | $375.35M | $375.35M | $370.35M | $312.63M | $300.48M | $284.21M | $267.51M | $262.41M | $255.10M | $250.30M | $242.84M | $298.02M | $282.57M | $256.79M | $240.03M | $248.87M | $224.60M | $211.47M | $199.12M | $195.97M | $175.38M | $141.55M | $130.37M | $122.09M | $113.38M | $119.79M | $119.87M | $99.44M | $73.11M |
| Low Forecast | $379.21M | $374.22M | $374.22M | $369.23M | $311.69M | $299.58M | $283.35M | $266.70M | $261.62M | $254.90M | $249.54M | $242.11M | $297.82M | $279.40M | $256.02M | $239.30M | $248.12M | $223.92M | $211.47M | $189.77M | $186.77M | $167.14M | $134.90M | $124.25M | $116.35M | $108.06M | $114.17M | $114.24M | $94.77M | $69.68M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.04% | 1.07% | 1.06% | 1.07% | 1.02% | - | 1.05% | 1.08% | 1.04% | 1.07% | 1.05% | 1.03% | 1.00% | 1.06% | 1.02% | 1.12% | 0.98% |
Axcelis's average Quarter revenue forecast for Mar 24 based on 1 analysts is $242.61M, with a low forecast of $242.11M, and a high forecast of $242.84M. ACLS's average Quarter revenue forecast represents a -21.81% decrease compared to the company's last Quarter revenue of $310.29M (Dec 23).
Axcelis EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $79.05M | $75.00M | $63.71M | $54.26M | $67.27M | $46.34M | - | $47.40M | $49.35M | $38.14M | $26.71M | $21.88M | $18.36M | $17.41M | $19.34M | $15.93M | $16.26M | $3.67M |
| Avg Forecast | $66.07M | $65.20M | $65.20M | $64.33M | $54.30M | $52.19M | $49.37M | $46.47M | $45.58M | $44.33M | $43.47M | $54.19M | $51.80M | $48.72M | $44.60M | $42.84M | $43.23M | $36.04M | $36.77M | $33.86M | $37.02M | $32.77M | $20.78M | $12.03M | $17.14M | $11.60M | $11.82M | $10.83M | $9.16M | $13.20M |
| High Forecast | $66.13M | $65.26M | $65.26M | $64.39M | $54.35M | $52.24M | $49.41M | $46.51M | $45.62M | $44.35M | $43.52M | $65.03M | $51.81M | $49.13M | $44.65M | $51.40M | $43.27M | $43.25M | $36.77M | $40.64M | $44.42M | $39.32M | $24.93M | $14.44M | $20.57M | $13.92M | $14.18M | $13.00M | $10.99M | $15.84M |
| Low Forecast | $65.93M | $65.06M | $65.06M | $64.19M | $54.19M | $52.08M | $49.26M | $46.37M | $45.48M | $44.32M | $43.38M | $43.35M | $51.78M | $48.58M | $44.51M | $34.27M | $43.14M | $28.84M | $36.77M | $27.09M | $29.61M | $26.21M | $16.62M | $9.63M | $13.71M | $9.28M | $9.45M | $8.66M | $7.33M | $10.56M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.53% | 1.54% | 1.43% | 1.27% | 1.56% | 1.29% | - | 1.40% | 1.33% | 1.16% | 1.29% | 1.82% | 1.07% | 1.50% | 1.64% | 1.47% | 1.77% | 0.28% |
1 analysts predict ACLS's average Quarter EBITDA for Mar 24 to be $54.19M, with a high of $65.03M and a low of $43.35M. This is -31.45% lower than Axcelis's previous annual EBITDA (Dec 23) of $79.05M.
Axcelis Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $71.06M | $65.93M | $61.58M | $47.70M | $56.99M | $40.28M | - | $41.61M | $35.75M | $27.52M | $18.91M | $16.48M | $14.67M | $10.79M | $13.30M | $11.22M | $9.71M | $704.00K |
| Avg Forecast | $96.02M | $94.05M | $94.38M | $92.41M | $70.52M | $63.51M | $57.51M | $51.61M | $49.81M | $46.86M | $44.76M | $44.88M | $66.15M | $58.07M | $47.94M | $35.48M | $46.53M | $26.00M | $32.73M | $28.04M | $26.81M | $23.64M | $14.70M | $9.06M | $13.70M | $7.19M | $8.13M | $7.63M | $5.47M | $2.53M |
| High Forecast | $96.14M | $94.17M | $94.50M | $92.53M | $70.61M | $63.59M | $57.58M | $51.68M | $49.87M | $46.92M | $44.82M | $53.85M | $66.82M | $58.75M | $48.00M | $42.57M | $46.59M | $31.20M | $32.73M | $33.65M | $32.17M | $28.37M | $17.65M | $10.88M | $16.43M | $8.63M | $9.75M | $9.16M | $6.57M | $3.04M |
| Low Forecast | $95.76M | $93.80M | $94.13M | $92.16M | $70.33M | $63.34M | $57.36M | $51.47M | $49.68M | $46.74M | $44.64M | $35.90M | $64.48M | $57.74M | $47.81M | $28.38M | $46.41M | $20.80M | $32.73M | $22.44M | $21.45M | $18.91M | $11.76M | $7.25M | $10.96M | $5.75M | $6.50M | $6.10M | $4.38M | $2.03M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.14% | 1.28% | 1.34% | 1.22% | 1.55% | - | 1.48% | 1.33% | 1.16% | 1.29% | 1.82% | 1.07% | 1.50% | 1.64% | 1.47% | 1.77% | 0.28% |
Axcelis's average Quarter net income forecast for Mar 24 is $44.88M, with a range of $35.90M to $53.85M. ACLS's average Quarter net income forecast represents a -36.84% decrease compared to the company's last Quarter net income of $71.06M (Dec 23).
Axcelis SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $33.93M | $33.91M | $31.86M | $28.89M | $31.34M | $29.56M | - | $23.87M | $26.48M | $23.41M | $23.39M | $20.40M | $22.58M | $19.41M | $19.48M | $17.24M | $17.51M | $15.76M |
| Avg Forecast | $55.80M | $55.07M | $55.07M | $54.34M | $45.87M | $44.08M | $41.70M | $39.25M | $38.50M | $37.45M | $36.72M | $25.74M | $43.75M | $41.15M | $37.67M | $20.35M | $36.51M | $22.13M | $31.05M | $16.09M | $19.86M | $20.11M | $18.20M | $11.22M | $21.07M | $12.94M | $11.90M | $11.72M | $9.86M | $56.75M |
| High Forecast | $55.86M | $55.12M | $55.12M | $54.39M | $45.91M | $44.13M | $41.74M | $39.28M | $38.54M | $37.46M | $36.76M | $30.89M | $43.76M | $41.50M | $37.71M | $24.42M | $36.55M | $26.55M | $31.05M | $19.30M | $23.84M | $24.14M | $21.83M | $13.46M | $25.29M | $15.53M | $14.28M | $14.07M | $11.84M | $68.10M |
| Low Forecast | $55.69M | $54.95M | $54.95M | $54.22M | $45.77M | $43.99M | $41.61M | $39.17M | $38.42M | $37.43M | $36.65M | $20.59M | $43.74M | $41.03M | $37.60M | $16.28M | $36.44M | $17.70M | $31.05M | $12.87M | $15.89M | $16.09M | $14.56M | $8.98M | $16.86M | $10.35M | $9.52M | $9.38M | $7.89M | $45.40M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.78% | 0.82% | 0.85% | 1.42% | 0.86% | 1.34% | - | 1.48% | 1.33% | 1.16% | 1.29% | 1.82% | 1.07% | 1.50% | 1.64% | 1.47% | 1.77% | 0.28% |
Axcelis's average Quarter SG&A projection for Mar 24 is $25.74M, based on 1 Wall Street analysts, with a range of $20.59M to $30.89M. The forecast indicates a -24.14% fall compared to ACLS last annual SG&A of $33.93M (Dec 23).
Axcelis EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $2.17 | $2.01 | $1.88 | $1.46 | $1.74 | $1.22 | - | $1.25 | $1.07 | $0.82 | $0.56 | $0.49 | $0.44 | $0.32 | $0.40 | $0.34 | $0.30 | $0.02 |
| Avg Forecast | $2.93 | $2.87 | $2.88 | $2.82 | $2.15 | $1.94 | $1.75 | $1.57 | $1.52 | $1.43 | $1.37 | $1.24 | $2.02 | $1.77 | $1.46 | $1.30 | $1.42 | $1.13 | $0.99 | $0.92 | $0.84 | $0.71 | $0.45 | $0.36 | $0.32 | $0.24 | $0.29 | $0.26 | $0.16 | $-0.01 |
| High Forecast | $2.93 | $2.87 | $2.88 | $2.82 | $2.15 | $1.94 | $1.76 | $1.58 | $1.52 | $1.43 | $1.37 | $1.24 | $2.04 | $1.79 | $1.46 | $1.30 | $1.42 | $1.13 | $0.99 | $0.96 | $0.87 | $0.74 | $0.46 | $0.37 | $0.33 | $0.25 | $0.30 | $0.27 | $0.17 | $-0.01 |
| Low Forecast | $2.92 | $2.86 | $2.87 | $2.81 | $2.15 | $1.93 | $1.75 | $1.57 | $1.52 | $1.43 | $1.36 | $1.24 | $1.97 | $1.76 | $1.46 | $1.30 | $1.42 | $1.12 | $0.99 | $0.90 | $0.82 | $0.70 | $0.44 | $0.35 | $0.31 | $0.23 | $0.28 | $0.25 | $0.16 | $-0.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.13% | 1.29% | 1.12% | 1.23% | 1.08% | - | 1.36% | 1.27% | 1.15% | 1.26% | 1.37% | 1.37% | 1.33% | 1.39% | 1.32% | 1.85% | -3.33% |
According to 1 Wall Street analysts, Axcelis's projected average Quarter EPS for Mar 24 is $1.24, with a low estimate of $1.24 and a high estimate of $1.24. This represents a -42.74% decrease compared to ACLS previous annual EPS of $2.17 (Dec 23).
Axcelis Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| INDI | indie Semiconductor | $3.51 | $9.00 | 156.41% | Buy |
| UCTT | Ultra Clean | $32.94 | $56.00 | 70.01% | Buy |
| KLIC | Kulicke and Soffa Industries | $38.57 | $65.00 | 68.52% | Hold |
| ONTO | Onto Innovation | $177.30 | $257.50 | 45.23% | Buy |
| ACLS | Axcelis | $96.98 | $137.00 | 41.27% | Buy |
| COHU | Cohu | $24.18 | $34.00 | 40.61% | Buy |
| TER | Teradyne | $121.45 | $153.18 | 26.13% | Buy |
| ASML | ASML | $752.79 | $905.67 | 20.31% | Buy |
| PLAB | Photronics | $22.00 | $25.50 | 15.91% | Buy |
| AMAT | Applied Materials | $174.75 | $201.30 | 15.19% | Buy |
| LRCX | Lam Research | $733.83 | $827.05 | 12.70% | Buy |
| KLAC | KLA | $702.80 | $590.28 | -16.01% | Buy |
ACLS Forecast FAQ
Is Axcelis a good buy?
Yes, according to 7 Wall Street analysts, Axcelis (ACLS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 85.71% of ACLS's total ratings.
What is ACLS's price target?
Axcelis (ACLS) average price target is $137 with a range of $100 to $174, implying a 41.27% from its last price of $96.98. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Axcelis stock go up soon?
According to Wall Street analysts' prediction for ACLS stock, the company can go up by 41.27% (from the last price of $96.98 to the average price target of $137), up by 79.42% based on the highest stock price target, and up by 3.11% based on the lowest stock price target.
Can Axcelis stock reach $150?
ACLS's highest twelve months analyst stock price target of $174 supports the claim that Axcelis can reach $150 in the near future.
What are Axcelis's analysts' financial forecasts?
Axcelis's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.16B (high $1.16B, low $1.16B), average EBITDA is $202.33M (high $202.52M, low $201.91M), average net income is $243.16M (high $243.46M, low $242.5M), average SG&A $170.9M (high $171.06M, low $170.54M), and average EPS is $7.42 (high $7.43, low $7.4). ACLS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.5B (high $1.5B, low $1.5B), average EBITDA is $260.79M (high $261.03M, low $260.24M), average net income is $376.87M (high $377.33M, low $375.85M), average SG&A $220.28M (high $220.48M, low $219.82M), and average EPS is $11.5 (high $11.51, low $11.47).
Did the ACLS's actual financial results beat the analysts' financial forecasts?
Based on Axcelis's last annual report (Dec 2022), the company's revenue was $920M, beating the average analysts forecast of $877.61M by 4.83%. Apple's EBITDA was $210.46M, beating the average prediction of $149.9M by 40.40%. The company's net income was $183.08M, beating the average estimation of $133.31M by 37.33%. Apple's SG&A was $111.07M, beating the average forecast of $105.78M by 5.00%. Lastly, the company's EPS was $5.54, beating the average prediction of $4.46 by 24.12%. In terms of the last quarterly report (Dec 2023), Axcelis's revenue was $310.29M, beating the average analysts' forecast of $297.92M by 4.15%. The company's EBITDA was $79.05M, beating the average prediction of $51.8M by 52.62%. Axcelis's net income was $71.06M, beating the average estimation of $66.15M by 7.42%. The company's SG&A was $33.93M, missing the average forecast of $43.75M by -22.44%. Lastly, the company's EPS was $2.17, beating the average prediction of $2.02 by 7.50%